These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 24925983)

  • 1. Buprenorphine detection in urine using liquid chromatography-high-resolution mass spectrometry: comparison with cloned enzyme donor immunoassay (ThermoFisher) and homogeneous enzyme immunoassay (immunalysis).
    Belsey SL; Couchman L; Flanagan RJ
    J Anal Toxicol; 2014 Sep; 38(7):438-43. PubMed ID: 24925983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Novel Enzyme Immunoassay for the Detection of Buprenorphine, Norbuprenorphine and Their Glucuronides in Urine.
    Schubert B; Pitterl F; Saxl B; Pavlic M
    J Anal Toxicol; 2019 Jun; 43(5):364-368. PubMed ID: 30753557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitation of Buprenorphine, Norbuprenorphine, Buprenorphine Glucuronide, Norbuprenorphine Glucuronide, and Naloxone in Urine by LC-MS/MS.
    Marin SJ; McMillin GA
    Methods Mol Biol; 2016; 1383():69-78. PubMed ID: 26660175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved buprenorphine immunoassay performance after urine treatment with β-glucuronidase.
    Snyder ML; Darragh A; Flood JG; Jones J; Ropar K; Jarolim P; Melanson SE
    J Anal Toxicol; 2014; 38(6):375-9. PubMed ID: 24802159
    [TBL] [Abstract][Full Text] [Related]  

  • 5. False-positive buprenorphine by CEDIA in patients prescribed amisulpride or sulpiride.
    Birch MA; Couchman L; Pietromartire S; Karna T; Paton C; McAllister R; Marsh A; Flanagan RJ
    J Anal Toxicol; 2013 May; 37(4):233-6. PubMed ID: 23471956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and GC-MS validation of a highly sensitive recombinant G6PDH-based homogeneous immunoassay for the detection of buprenorphine and norbuprenorphine in urine.
    Wang G; Vincent M; Rodrigues W; Agrawal A; Moore C; Barhate R; Abolencia E; Coulter C; Soares J; Zheng YF; Taylor C; Morjana N
    J Anal Toxicol; 2007 Sep; 31(7):377-82. PubMed ID: 17725885
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of direct injection electrospray LC-MS/MS for confirmation of opiates in urine drug testing.
    Gustavsson E; Andersson M; Stephanson N; Beck O
    J Mass Spectrom; 2007 Jul; 42(7):881-9. PubMed ID: 17535017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the Immunalysis microplate ELISA for the detection of buprenorphine and its metabolite norbuprenorphine in urine.
    Miller EI; Torrance HJ; Oliver JS
    J Anal Toxicol; 2006 Mar; 30(2):115-9. PubMed ID: 16620543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a direct high-capacity target screening approach for urine drug testing using liquid chromatography-time-of-flight mass spectrometry.
    Saleh A; Stephanson NN; Granelli I; Villén T; Beck O
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Nov; 909():6-13. PubMed ID: 23153637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry.
    Kronstrand R; Seldén TG; Josefsson M
    J Anal Toxicol; 2003 Oct; 27(7):464-70. PubMed ID: 14607001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples.
    Favretto D; Frison G; Vogliardi S; Ferrara SD
    Rapid Commun Mass Spectrom; 2006; 20(8):1257-65. PubMed ID: 16550495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo glucuronidation of buprenorphine and norbuprenorphine determined by liquid chromatography-electrospray ionization-tandem mass spectrometry.
    Huang W; Moody DE; McCance-Katz EF
    Ther Drug Monit; 2006 Apr; 28(2):245-51. PubMed ID: 16628138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Determination of buprenorphine in urine].
    Hegstad S; Christophersen AS; Khiabani HZ
    Tidsskr Nor Laegeforen; 2008 Jan; 128(2):184-5. PubMed ID: 18202730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse.
    Melanson SE; Snyder ML; Jarolim P; Flood JG
    J Anal Toxicol; 2012 Apr; 36(3):201-6. PubMed ID: 22417836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzyme immunoassay validation for the detection of buprenorphine in urine.
    Cirimele V; Kintz P; Lohner S; Ludes B
    J Anal Toxicol; 2003 Mar; 27(2):103-5. PubMed ID: 12670004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and efficient liquid chromatographic-tandem mass spectrometric method for opiates in urine drug testing - importance of 6-acetylmorphine and reduction of analytes.
    Andersson M; Stephanson N; Ohman I; Terzuoli T; Lindh JD; Beck O
    Drug Test Anal; 2014 Apr; 6(4):317-24. PubMed ID: 23720205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-sensitivity analysis of buprenorphine, norbuprenorphine, buprenorphine glucuronide, and norbuprenorphine glucuronide in plasma and urine by liquid chromatography-mass spectrometry.
    Regina KJ; Kharasch ED
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Nov; 939():23-31. PubMed ID: 24095872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative testing of buprenorphine and norbuprenorphine to identify urine sample spiking during office-based opioid treatment.
    Suzuki J; Zinser J; Issa M; Rodriguez C
    Subst Abus; 2017; 38(4):504-507. PubMed ID: 28723256
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Issues pertaining to the analysis of buprenorphine and its metabolites by gas chromatography-mass spectrometry.
    Wang YS; Lin DL; Yang SC; Wu MY; Liu RH; Su LW; Cheng PS; Liu C; Fuh MR
    J Chromatogr A; 2010 Mar; 1217(10):1688-94. PubMed ID: 20122691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary buprenorphine concentrations in patients treated with suboxone as determined by liquid chromatography-mass spectrometry and CEDIA immunoassay.
    Hull MJ; Bierer MF; Griggs DA; Long WH; Nixon AL; Flood JG
    J Anal Toxicol; 2008 Sep; 32(7):516-21. PubMed ID: 18713521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.